glp 1 in europe Oral GLP-1 Market to Rise at 35.05% CAGR till 2035 GLP-1s in the spotlight at
Description
Many programs combine medication with nutritional guidance and lifestyle changes to improve results
Notably, despite the positive effects on renal outcomes, the study also reported an increased incidence of gastrointestinal side effects, including nausea, vomiting, and diarrhea, though these were not statistically significant [89]
The actual effect of the medication is nearly the same
Many people experience mild digestive discomfort when first starting GLP-1 drugs, which typically improves over several weeks
